A phase I and pharmacokinetic study of ixabepilone in combination with Carboplatin in patients with advanced solid malignancies.
about
A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial.Profile and potential of ixabepilone in the treatment of pancreatic cancerPoly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent.Advancements in the Treatment of Metastatic Breast Cancer (MBC): The Role of Ixabepilone.Ixabepilone as monotherapy or in combination for the treatment of advanced breast cancer.Emerging mitotic inhibitors for non-small cell carcinoma.
P2860
A phase I and pharmacokinetic study of ixabepilone in combination with Carboplatin in patients with advanced solid malignancies.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
A phase I and pharmacokinetic ...... h advanced solid malignancies.
@en
A phase I and pharmacokinetic ...... h advanced solid malignancies.
@nl
type
label
A phase I and pharmacokinetic ...... h advanced solid malignancies.
@en
A phase I and pharmacokinetic ...... h advanced solid malignancies.
@nl
prefLabel
A phase I and pharmacokinetic ...... h advanced solid malignancies.
@en
A phase I and pharmacokinetic ...... h advanced solid malignancies.
@nl
P2093
P1476
A phase I and pharmacokinetic ...... th advanced solid malignancies
@en
P2093
David Fyfe
Fouad Namouni
James Carmichael
Mark Verrill
Marvin Cohen
Melanie Griffin
Paula Hewitt
Ruth Plummer
P304
P356
10.1158/1078-0432.CCR-08-0471
P407
P577
2008-12-01T00:00:00Z